EAM Global Investors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-49,129
Closed -$1.77M 122
2019
Q2
$1.77M Hold
49,129
0.75% 49
2019
Q1
$1.55M Hold
49,129
0.69% 68
2018
Q4
$1.24M Sell
49,129
-13,920
-22% -$358K 0.68% 75
2018
Q3
$1.82M Sell
63,049
-37,512
-37% -$702K 0.74% 35
2018
Q2
$1.23M Sell
100,561
-51,324
-34% -$589K 0.6% 87
2018
Q1
$1.21M Buy
151,885
+2,612
+2% +$16.1K 0.63% 66
2017
Q4
$1.1M Buy
+149,273
New +$931K 0.56% 71

Other funds holding CDNA

EAM Global Investors's CDNA Position: Q3 2019 in Review

EAM Global Investors sold out of CareDx (CDNA) in Q3 2019, closing a stake of 49,129 shares — an estimated $1.77M sold.

EAM Global Investors first reported a position in CDNA in Q4 2017 and held it in 7 quarters. The position peaked at $1.82M in Q3 2018. 174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

  • EAM Global Investors reported no remaining CareDx position as of Q3 2019 after selling out during the quarter.
  • EAM Global Investors sold 49,129 CareDx shares in Q3 2019, an estimated $1.77M.
  • EAM Global Investors first reported a position in CareDx in Q4 2017 and held it in 7 quarters.
  • EAM Global Investors's CareDx position peaked at $1.82M in Q3 2018.
  • 174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on EAM Global Investors's 13F filing for Q3 2019, filed 13 Nov 2019.